An economon model of drug addiction S. Stevens Negus Theoretical and Methodological Perspective Open access 26 January 2024 Pages: 417 - 425
The neutral CB1 antagonist AM6527 reduces ethanol seeking, binge-like consumption, reinforcing, and withdrawal effects in male and female mice Jimit Girish RaghavHritik KumarKlaus A. Miczek Original Investigation 25 November 2023 Pages: 427 - 443
The anterior insula and its projection to amygdala nuclei modulate the abstinence-exacerbated expression of conditioned place preference Andrés AgoitiaApolinar Cruz-SanchezFederico Bermúdez-Rattoni Original Investigation Open access 27 November 2023 Pages: 445 - 459
Effects of testosterone enanthate on aggression, risk-taking, competition, mood, and other cognitive domains during 28 days of severe energy deprivation Harris R. LiebermanJohn A. CaldwellStefan M. Pasiakos Original Investigation Open access 01 December 2023 Pages: 461 - 478
The imidazoline I2 receptor agonist 2-BFI reduces abuse-related effects of morphine: self-administration and drug discrimination Justin N. SiemianKristen WoodhouseJun-Xu Li Original Investigation 30 December 2023 Pages: 479 - 487
Pharmaco-toxicological effects of the novel tryptamine hallucinogen 5-MeO-MiPT on motor, sensorimotor, physiological, and cardiorespiratory parameters in mice—from a human poisoning case to the preclinical evidence Marta BassiSabrine BilelMatteo Marti Original Investigation Open access 12 January 2024 Pages: 489 - 511
Cue-exposure treatment influences resting-state functional connectivity—a randomized controlled fMRI study in alcohol use disorder Àlvar Farré-ColomésHaoye TanSabine Vollstädt-Klein Original Investigation Open access 23 January 2024 Pages: 513 - 524
The relevance between abnormally elevated serum ceramide and cognitive impairment in Alzheimer’s disease model mice and its mechanism Xin LiuYongzeng JinTong Chen Original Investigation 26 January 2024 Pages: 525 - 542
A practice quit model to test early efficacy of medications for alcohol use disorder in a randomized clinical trial Lara A. RayWave-Ananda BaskervilleKaren Miotto Original Investigation 28 November 2023 Pages: 543 - 553
Mice with an autism-associated R451C mutation in neuroligin-3 show intact attention orienting but atypical responses to methylphenidate and atomoxetine in the mouse-Posner task Shuting LiCarlos MayEmma L. Burrows Original Investigation 03 January 2024 Pages: 555 - 567
Pharmacological diacylglycerol lipase inhibition impairs contextual fear extinction in mice Liorimar Ramos-MedinaLuis E. Rosas-VidalSachin Patel Original Investigation Open access 06 January 2024 Pages: 569 - 584
Adult consequences of repeated nicotine and Δ9-tetrahydrocannabinol (THC) vapor inhalation in adolescent rats Arnold GutierrezKevin M. CreehanMichael A. Taffe Original Investigation Open access 29 January 2024 Pages: 585 - 599
Rapamycin attenuates reconsolidation of a backwards-conditioned aversive stimuli in female mice Jared TraskPhillip E. MacCallumJacqueline J. Blundell Original Investigation 05 February 2024 Pages: 601 - 612
Individual differences in GHB consumption in a new voluntary GHB self-administration model in outbred rats Casper J. H. WolfMarcia SpoelderJudith R. Homberg Original Investigation Open access 09 February 2024 Pages: 613 - 625
The role of the peripheral and central adrenergic system in the construction of the subjective emotional experience of panic Jette H. de VosKoen R. J. SchruersNicole K. Leibold Original Investigation Open access 16 February 2024 Pages: 627 - 635
